Cronos Group Inc.
Cronos Group Inc. (CRON.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CRON.TO · as of Jun 8, 2026
Key Statistics
Explore Cronos Group Inc. Data
cron.to stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 25.0%
Competitors & Peers
cron.to competitorsCRON.TO
CL.CN
EXE.TO
GTII.CN
GUD.TO
ROMJ.VStock Performance
Full HistoryAbout Cronos Group Inc.
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channe…
what is cronos group inc. · cron.to stock overview · cronos group inc. company profile · who is cronos group inc. ceo · cron.to TSX · cronos group inc. headquarters · cronos group inc. business segments
About Stock Overview & Key Data
Cronos Group Inc. (CRON.TO) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on TSX since Dec 17, 2014. As of the latest trading session, CRON.TO stock price is $3.85, with a market capitalization of $1.4B. The stock has returned +44.19% over the past 12 months and +6.94% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Cronos Group Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Cronos Group Inc. reported revenue of $149.2M and net income of -$9.6M. For detailed data — including Cronos Group Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cronos Group Inc. (CRON.TO) stock price is $3.85. The stock is traded on TSX under the ticker symbol CRON.TO. The 52-week range is $2.54 – $4.66.